Darifenacin Hydrobromide Darifenacin HBr CAS 133099-07-7 Intendi ≥99.0% API Factory High Quality
Manufacturer Supple cum High puritate et stabulo Quality
Chemical Name: Darifenacin Hydrobromide
CAS: 133099-07-7
Darifenacin hydrobromida est receptaculum muscarinicum selectivum M3 contra incontinentiam urinae tractandi usus et syndrome vesicae excitativae.
API High Quality, Commercial Production
| Nomen chemicum | Darifenacin Hydrobromide |
| Synonyma | Darifenacin HBr;UK-88525;Enablex |
| CAS Number | 133099-07-7 |
| CATTUS Number | RF-API94 |
| Stock Status | In Stock, Productio Ascendite usque ad Centum chiliogrammata |
| Formulae hypotheticae | C28H30N2O2.HBr |
| M. Pondus | 507.46 |
| Liquescens punctum | 228.0~230.0℃ |
| Solubilitas | DMSO: Solutum 20mg/ml, Serenum |
| Repono Temperature | Copia Diu terminus in -20℃ |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Crystallina pulveris alba |
| Solubilitas | Parce solutum in Methanolo, Paulo solutum in Aqua, et fere Insolubile in Chloroform. |
| Lepidium sativum IR | Spectrum specimen correspondet relationis vexillum |
| Lepidium sativum HPLC | Retentionis tempus solutionis maioris partis exempli solutionis correspondet solutioni normae |
| Substantiae cognatae | |
| Maximilianus.una immunditia | ≤0.50% |
| Totalis immunditias | ≤1.0% |
| Optical Isomer | ≤0.50% |
| RELICTUM Solvents | |
| Ethyl Acetate | ≤0.50% |
| Ethanol | ≤0.50% |
| Methanol | ≤0.30% |
| Acetone | ≤0.50% |
| 1-Butanol | ≤0.50% |
| Damnum in Siccatio | ≤1.0% (Arida ad 105℃ in aura electrica flante dryer usque ad constantem pondus) |
| Residere in Ignition | ≤0.10% |
| Metalla gravis | ≤20ppm |
| Assay | ≥99.0% (ex exaruit basis) |
| Fasciae vita | XXIV Menses |
| Test Standard | Enterprise Standard |
| Consuetudinem | API, Vesica Overactive |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
Darifenacin Hydrobromida, Darifenacin HBr (CAS 133099-07-7), ore activo, semel in die receptor selectivus M3, immissa est ad curationem vesicae overactivae in patientibus cum indicia urgentis urinae incontinentiae, necessitatis et frequentiae.Medicamentum selective inhibet receptorem M3 in musculo detrusore, dum receptoribus M1 et M2 parcit, qui in systemate nervoso centrali et munere respective cardiovasculari involvi creduntur.Compositum a Pfizer principio enucleatum et licentiatum Novartis et Bayer fuit.
